Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of dapagliflozin on nighttime blood pressure in type 2 diabetes
2017-002125-38Phase 4Terminated
- Sponsor
- LM Diagnósticos
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and hypertension (HTN) comparing Dapagliflozin 10 mg with Placebo (2 arms). Primary endpoint: Change in mean nocturnal blood pressure. Started Sep 2018; status: terminated.
02
Drugs
dapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)
Beyond the preview
Go deeper on 2017-002125-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002125-38.